Loading…
Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy
SCIT-treated subjects reported markedly less seasonal symptoms than did untreated subjects with SAR (Fig 1, G, and Table E2). [...]in allergic individuals, there was a correlation between visual analog scales and the proportion of ILC2s during the pollen season (r = 0.52, P = .02) (Fig 1, H). Studie...
Saved in:
Published in: | Journal of allergy and clinical immunology 2014-11, Vol.134 (5), p.1193-1195.e4 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | SCIT-treated subjects reported markedly less seasonal symptoms than did untreated subjects with SAR (Fig 1, G, and Table E2). [...]in allergic individuals, there was a correlation between visual analog scales and the proportion of ILC2s during the pollen season (r = 0.52, P = .02) (Fig 1, H). Studies in humans show the presence of ILC2s in several inflammatory diseases including atopic dermatitis and nasal polyps.4,9 A limitation of our study is that the immunotherapy group did not have a preimmunotherapy level of ILC2s determined. [...]an investigation of ILC2s and indeed other ILC subtypes in the context of a prospective, controlled study of allergen immunotherapy is required to confirm and elaborate on these findings. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2014.07.029 |